TABLE 1.

Clinical characteristics of the HCC patients used in this study.

	TCGA cohort	GEO cohort
Number of patients	371	209
Age (median, range)	61 (16–90)	51 (21–77)
Gender(%)
Female	120 (32.3%)	26 (12.4%)
Male	251 (67.7%)	183 (87.6%)
Race
White	185 (49.9%)	NA
Asian	158 (42.6%)	NA
Black or American	18 (4.8%)	NA
Unknown	10 (2.7%)	NA
Grade(%)
Grade 1	55 (14.8%)	NA
Grade 2	178 (50.0%)	NA
Grade 3	120 (32.3%)	NA
Grade 4	13 (3.5%)	NA
Unknown	5 (1.3%)	NA
Stage (%)
Ⅰ	174 (46.9%)	90 (43.1%)
Ⅱ	85 (22.9%)	74 (35.4%)
Ⅲ	84 (22.6%)	43 (20.6%)
Ⅳ	4 (1.1%)	NA
unknown	24 (6.4%)	2 (0.9%)
Child–Pugh(%)
A	222 (59.8%)	NA
B	21 (5.7%)	NA
C	1 (0.3%)	NA
unknown	127 (34.2%)	NA
Main tumor Size(%)
>5 cm	NA	75 (35.9%)
≤5 cm	NA	133 (63.6%)
Unknown	NA	1 (0.5%)
Survival status
OS days (median)	602	1,581